[{"Assets_0_Q2_USD":309862614.0,"CommonStockSharesOutstanding_0_Q2_shares":55186745.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-62938035.0,"NetIncomeLoss_1_Q2_USD":-37441164.0,"NetIncomeLoss_2_Q2_USD":-72276928.0,"StockholdersEquity_0_Q2_USD":256768362.0,"Ticker":"ITCI","CIK":"1567514","name":"INTRA-CELLULAR THERAPIES, INC.","OfficialName":"Intra-Cellular Therapies Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5718578003.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]